Pharma / Biotech

Bavencio Receives New Indication for Maintenance in Advanced Urothelial Carcinoma

The FDA granted a new indication for avelumab for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma that has not progressed on first-line platinum-containing chemotherapy.

Source link

Related posts

How to deal with prednisone withdrawal


ARIMIDEX (Anastrozole) Tablet [ANI Pharmaceuticals, Inc.]


Centralized Anticoagulation Hub Appears Promising for VA


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World